Thyroid hormone level is associated with motor symptoms in de novo Parkinson’s disease (original) (raw)
Goldstein DS, Holmes CS, Dendi R, Bruce SR, Li ST (2002) Orthostatic hypotension from sympathetic denervation in Parkinson’s disease. Neurology 58:1247–1255 ArticleCASPubMed Google Scholar
Matsui H, Udaka F, Oda M et al (2005) Metaiodobenzylguanidine (MIBG) uptake in Parkinson’s disease also decreases at thyroid. Ann Nucl Med 19:225–229 ArticleCASPubMed Google Scholar
Jang W, Kim JS, Cho JW, Ahn JY, Choi YY, Kim HT (2013) Thyroid MIBG uptake in Parkinson’s disease with diabetes mellitus. Clin Auton Res 23:221–224 ArticlePubMed Google Scholar
Tipre DN, Goldstein DS (2005) Cardiac and extracardiac sympathetic denervation in Parkinson’s disease with orthostatic hypotension and in pure autonomic failure. J Nucl Med 46:1775–1781 CASPubMed Google Scholar
Melander A, Ericson LE, Sundler F, Ingbar SH (1974) Sympathetic innervation of the mouse thyroid and its significance in thyroid hormone secretion. Endocrinology 94:959–966 ArticleCASPubMed Google Scholar
Silva JE, Bianco SD (2008) Thyroid-adrenergic interactions: physiological and clinical implications. Thyroid 18:157–165 ArticleCASPubMed Google Scholar
Caradoc-Davies TH (1986) Resolution of dyskinesia and the “on–off” phenomenon in thyrotoxic patients with Parkinson’s disease after antithyroid treatment. Br Med J (Clin Res Ed) 293:38–39 ArticleCAS Google Scholar
Kim HT, Edwards MJ, Lakshmi Narsimhan R, Bhatia KP (2005) Hyperthyroidism exaggerating parkinsonian tremor: a clinical lesson. Parkinsonism Relat Disord 11:331–332 ArticlePubMed Google Scholar
Guerin V, Guyot C, Hartemann P (1990) Dysthyroidism and Parkinson’s disease. Ann Endocrinol (Paris) 51:43–45 CAS Google Scholar
Prakash KM (2010) Hyperthyroidism “masked” the levodopa response in newly diagnosed Parkinson’s disease patients. Parkinsonism Relat Disord 16:691–692 ArticlePubMed Google Scholar
Flotats A, Carrio I, Agostini D, Le Guludec D, Marcassa C, Schafers M et al (2010) Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology. Eur J Nucl Med Mol Imaging 37:1802–1812 ArticlePubMed Google Scholar
Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease. A clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184 ArticlePubMed CentralCASPubMed Google Scholar
Spiegel J, Hellwig D, Samnick S et al (2007) Striatal FP-CIT uptake differs in the subtypes of early Parkinson’s disease. J Neural Transm 114:331–335 ArticleCASPubMed Google Scholar
Sapin R, Schlienger JL (2003) Thyroxine (T4) and tri-iodothyronine (T3) determinations: techniques and value in the assessment of thyroid function. Ann Biol Clin (Paris) 61:411–420 CAS Google Scholar
Wingert TD, Hershman JM (1997) Sinemet and thyroid function in Parkinson’s disease. Neurology 29:1073–1074 Article Google Scholar
Mannisto P, Mattila J, Kaakkola S (1981) Possible involvement of nigrostriatal dopamine system in the inhibition of thyrotropin secretion in the rat. Eur J Pharmacol 76:403–409 ArticleCASPubMed Google Scholar
Schilling JC, Adamus WS, Palluk R (1992) Neuroendocrine and side effect profile of pramipexole, a new dopamine receptor agonist, in humans. Clin Pharmacol Ther 51:541–548 ArticleCASPubMed Google Scholar
Munhoz RP, Teive HA, Troiano AR et al (2004) Parkinson’s disease and thyroid dysfunction. Parkinsonism Relat Disord 10:381–383 ArticlePubMed Google Scholar
Bonuccelli U, D’Avino C, Caraccio N et al (1999) Thyroid function and autoimmunity in Parkinson’s disease: a study of 101 patients. Parkinsonsim Relat Disord 5:49–53 ArticleCAS Google Scholar
Tandeter H, Levy A, Gutman G, Shvartzman P (2001) Subclinical thyroid disease in patients with Parkinson’s disease. Arch Gerontol Geriatr 33:295–300 ArticleCASPubMed Google Scholar
Falaschi P, Martocchia A, Proietti A et al (2004) The hypothalamic-pituitary-thyroid axis in subjects with subclinical thyroid diseases: the impact of the negative feedback mechanism. Neuro Endocrinol Lett 25:292–296 PubMed Google Scholar
Orimo S, Ozawa E, Nakade S, Sugimoto T, Mizusawa H (1999) (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson’s disease. J Neurol Neurosurgery Psychiatry 67(2):189–194 ArticleCAS Google Scholar
Oka H, Toyoda C, Yogo M, Mochio S (2011) Cardiovascular dysautonomia in de novo Parkinson’s disease without orthostatic hypotension. Eur J Neurol 18:286–292 ArticleCASPubMed Google Scholar
Orimo S, Uchihara T, Nakamura A et al (2008) Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson’s disease. Brain 131:642–650 ArticlePubMed Google Scholar
Cardinali DP, Vacas MI, Gejman PV (1981) The sympathetic superior cervical ganglia as peripheral neuroendocrine centers. J Neural Transm 52:1–21 ArticleCASPubMed Google Scholar
Del Tredici K, Hawkes CH, Ghebremedhin E, Braak H (2010) Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson’s disease. Acta Neuropathol 119:703–713 ArticlePubMed Google Scholar
Imamura Y, Ando H, Ashihara T et al (1996) Myocardial adrenergic nervous activity is intensified in patients with heart failure without left ventricular volume or pressure overload. J Am Coll Cardiol 28:371–375 ArticleCASPubMed Google Scholar
Sisson JC, Shapiro B, Meyers L et al (1987) Metaiodobenzylguanidine to map scintigraphically the adrenergic nervous system in man. J Nucl Med 28:1625–1636 CASPubMed Google Scholar
Tandeter HB, Shvartzman P (1993) Parkinson’s disease camouflaging early signs of hypothyroidism. Postgrad Med 94:187–190 CASPubMed Google Scholar
Garcia-Moreno JM, Chacon J (2002) Hypothyroidism concealed by Parkinson’s disease. Rev Neurol 35:741–742 CASPubMed Google Scholar
Garcia-Moreno JM, Chacon-Pena J (2003) Hypothyroidism and Parkinson’s disease and the issue of diagnostic confusion. Mov Disord 18:1058–1059 ArticlePubMed Google Scholar
Samuels MH, Henry P, Ridqway EC (1992) Effects of dopamine and somatostatin on pulsatile pituitary glycoprotein secretion. J Clin Endocrinol Metab 74:217–222 CASPubMed Google Scholar
Rossi C, Frosini D, Volterrani D, De Feo P, Unti E, Nicoletti V et al (2010) Differences in nigro-striatal impairment in clinical variants of early Parkinson’s disease: evidence from a FP-CIT SPECT study. Eur J Neurol 17:626–630 ArticleCASPubMed Google Scholar